Akero Therapeutics, Inc. Deferred Offering Costs
Akero Therapeutics, Inc. had Deferred Offering Costs of $524.00 thousand as of 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2022-02-25
- 2021-12-31: Deferred Offering Costs $524.00K.
- 2020-12-31: Deferred Offering Costs $0.00; Deferred Offering Costs as first filed $46.00K.
- 2019-12-31: Deferred Offering Costs $0.00.
- 2019-09-30: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2021-12-31 | $524.00K 10-K · filed 2022-02-25 | |
| 2020-12-31 | $0.00 10-K · filed 2022-02-25 | $46.00K 10-K · filed 2021-03-16 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-16 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-12 | |
| 2018-12-31 | $361.00K 10-K · filed 2020-03-16 |